What Is A Blood Thinner?
A blood thinner prevents the blood from clotting both internally and in open wounds. Xarelto blocks the thrombin in the blood that causes clotting, and that is designed to help patients who are at risk of getting blood clots. Blood thinners are designed to prevent dangerous leg and lung blood clots, and they also help to prevent strokes.
What Went Wrong With Xarelto?
Has The FDA Done A Recall On Xarelto?
Once the FDA has officially approved a drug for resale, it is very hesitant to recall the drug without proof of significant harm to the public. In the case of Xarelto, the FDA has not yet issued any type of recall as of October 2016. The FDA has issued:
- Two black box warnings (large black labels put on the product packaging as a warning) in August 2013 and December 2014
- A January 2014 warning against the use of Xarelto in certain medical situations and a statement that there is no antidote for Xarelto once it is in the patient's system
- A March 2014 warning recommending that patients on Xarelto wait until the drug is out of their system before having any spinal procedures done
The first bellwether trials were scheduled to take place in the fall of 2016 in New Orleans. But on September 21, 2016, those trials were officially delayed because the NBA All-Star game was to be played in New Orleans around the time of the trials and officials felt that having those two events taking place at the same time would be a logistical nightmare.
It was revealed that 80 bellwether cases are going to be scheduled to be heard in New Orleans at some point in early 2017. At the same time, it is estimated that another 800 lawsuits could start against Janssen Pharmaceuticals in the Philadelphia Complex Litigation Center. Janssen is already involved in several other cases regarding some of its other medications in the Philadelphia Complex Litigation Center.
When the FDA will not ban or recall a drug, victims feel it necessary to file lawsuits to get justice. Starting in early 2017, we will be able to see whether or not victims of Xarelto will get the justice they feel they deserve.
About Michael Monheit, Esq.
Michael Monheit, the managing attorney at Monheit Law, has been working to assist individuals and families who have been harmed by defective drugs and products. In fact, Mr. Monheit served on the Plaintiff’s Steering and Executive Committee for MDL 1148. He understands how stressful it can be to stand up to a major corporation and is committed to making sure that plaintiffs know they have someone on their side.
No comments:
Post a comment
Pharmaceutical Microbiology Resources